As an example, our analysis results highlight the significant increase in the methylation level of PRMT1’s promoter in BRCA, LUAD, and LUSC compared to the control groups (P<0.05) (Fig 1A), regardless of the cancer stage, even though the gene was significantly upregulated in LUSC only (Fig 1B). This evidence concerns the gene PRMT1 and cancer.